Hem › Övervikt
Kliniska studier för Övervikt som rekryterar i USA
204 studier för Övervikt rekryterar deltagare vid platser över hela USA.
Städer med flest studier
- San Antonio, TX34 studier
- Houston, TX33 studier
- Chicago, IL28 studier
- Orlando, FL27 studier
- Las Vegas, NV23 studier
- Miami, FL23 studier
- Atlanta, GA20 studier
- Dallas, TX20 studier
- Washington, DC19 studier
- New York City, NY19 studier
- Jacksonville, FL19 studier
- Austin, TX18 studier
- Havelock, NC17 studier
- Baltimore, MD17 studier
- Concord, CA16 studier
- Birmingham, AL16 studier
- Tucson, AZ15 studier
- Los Angeles, CA15 studier
- Charlotte, NC15 studier
- St. Louis, MO15 studier
- Louisville, KY15 studier
- Phoenix, AZ15 studier
- Johns Creek, GA14 studier
- Cincinnati, OH14 studier
- Philadelphia, PA14 studier
- Indianapolis, IN13 studier
- San Diego, CA13 studier
- Columbus, OH13 studier
- Rochester, NY13 studier
- Salt Lake City, UT13 studier
- Greensboro, NC12 studier
- Escondido, CA12 studier
- Boston, MA12 studier
- Honolulu, HI11 studier
- Wilmington, NC11 studier
- Arlington, VA11 studier
- South Fulton, GA11 studier
- Grand Prairie, TX11 studier
- The Woodlands, TX10 studier
- Pittsburgh, PA10 studier
Efter delstat
- Alabama31 studier
- Arizona29 studier
- Arkansas6 studier
- Colorado11 studier
- Connecticut16 studier
- District of Columbia7 studier
- Florida55 studier
- Georgia36 studier
- Hawaii11 studier
- Idaho19 studier
- Illinois38 studier
- Indiana16 studier
- Iowa9 studier
- Kalifornien64 studier
- Kansas26 studier
- Kentucky21 studier
- Louisiana23 studier
- Maryland37 studier
- Massachusetts24 studier
- Michigan19 studier
- Minnesota13 studier
- Mississippi11 studier
- Missouri33 studier
- Montana6 studier
- Nebraska7 studier
- Nevada24 studier
- New Hampshire3 studier
- New Jersey16 studier
- New Mexico4 studier
- New York45 studier
- North Carolina40 studier
- North Dakota8 studier
- Ohio35 studier
- Oklahoma18 studier
- Oregon13 studier
- Pennsylvania32 studier
- Rhode Island13 studier
- South Carolina35 studier
- South Dakota4 studier
- Tennessee25 studier
- Texas55 studier
- Utah22 studier
- Virginia33 studier
- Washington23 studier
- Wisconsin8 studier
Nyligen uppdaterade studier
Officiell studietext (engelska)
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Rekryterar
Ålder 21 till 65 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07090005Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07752979A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 85 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07793929AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT07533175A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RekryterarFas 3
Ålder 8 till 18 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07253285Two-Week Stair-Climbing Exercise Snacks and Metabolic Health in Adults With Overweight or Obesity: A Pilot Study
RekryterarFriska volontärer välkomna
Ålder 18 till 35 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07849439A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT07823608FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
Rekryterar
Ålder 18 till 75 · Alla kön · Uppdaterad 29 sep. 2026 · NCT06724406Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT07685808AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07668414Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
RekryterarFas 2
Ålder 18 till 75 · Alla kön · Uppdaterad 28 sep. 2026 · NCT07837973A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07794579Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
RekryterarFas 1
Ålder 18 till 65 · Alla kön · Uppdaterad 28 sep. 2026 · NCT07399678Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
RekryterarFas 2Friska volontärer välkomna
Ålder 18 till 60 · Kvinnor · Uppdaterad 28 sep. 2026 · NCT03407079A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07595549Physical and Behavioral Traits of Overweight and Obese Adults
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 18 till 100 · Alla kön · Uppdaterad 28 sep. 2026 · NCT00428987Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
RekryterarFas 1Friska volontärer välkomna
Ålder 18 till 65 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07594093A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RekryterarFas 3
Ålder 6 till 17 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekryterarFas 3
Ålder 18 till 70 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06937086A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
RekryterarFas 1
Ålder 18 till 70 · Alla kön · Uppdaterad 23 sep. 2026 · NCT07803744A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekryterarFas 3
Ålder 45 till 99 · Alla kön · Uppdaterad 22 sep. 2026 · NCT07037433Från ClinicalTrials.gov, data hämtad 2 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.